Mitochondrial dysfunction has been implicated in the pathogenesis of a plethora of neurodegenerative disorders (e.g., stroke, Parkinson's, amyotrophic lateral sclerosis, Huntington's, Alzheimer's, etc.). However, effective models useful for elucidating mechanisms and therapies associated with neuronal mitochondrial dysfunction are lacking. This invention describes a method that allows an in vivo, conditional, and cell- type specific expression of mitochondrially-targeted proteins.
Research tool to identify the role of cell-type specific mitochondrial dysfunction
-Provides a transgenic animal model that can be used to develop drugs that target specific neuronal mitochondrial populations.
-Provides a transgenic animal model that can be used to screen small molecules or compounds that promote neuronal mitochondrial protection
Stage of Development
A non-human transgenic animal model has been made that allows for the identification of mitochondria in a specific cell type